<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00529828</url>
  </required_header>
  <id_info>
    <org_study_id>NL15599.081.07</org_study_id>
    <nct_id>NCT00529828</nct_id>
  </id_info>
  <brief_title>Health Effects of CLA Versus Industrial Trans Fatty Acids</brief_title>
  <acronym>CLARINeT</acronym>
  <official_title>Health Effects of CLA Versus Industrial Trans Fatty Acids in Healthy Volunteers (CLARINeT-Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VU University of Amsterdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The knowledge of the health effects of CLA on the human body is limited. However, CLA
      supplements are sold over the counter in several countries and various techniques are used to
      increase the content of CLA in food.

      The CLARINeT study will be performed to investigate the effect of CLA on blood lipoproteins,
      inflammatory markers, blood pressure and insulin status in human volunteers relative to
      industrial trans fatty acids and to oleic acid.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It will be a double-blind randomized multiple cross-over trial with 3 treatments:

        -  CLA;

        -  Industrial trans fatty acids (as a positive control);

        -  Oleic acid (Cis 18:1, the monounsaturated fatty acid in unhydrogenated vegetable oils)
           as a reference fat.

      Each volunteer receives each diet for three weeks, in random order, for a total of 9 weeks.
      Three weeks is sufficient to reach new stable lipoprotein levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total cholesterol</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>HDL cholesterol</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>LDL cholesterol</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Apo B</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Triglycerides</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin status markers : HOMA; QUICKY</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers: C-RP; IL-6; E-selectin; MCP-1; s-TNF-R1; s-TNF-R2; IFg</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatty acid composition of cholesteryl esters and erythrocytes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proteomics</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iso-prostanes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure and heart rate</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Consumption of CLA enriched food</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-65 years

          -  healthy

        Exclusion Criteria:

          -  serum total cholesterol &gt;= 6,5 mmol/L

          -  serum triglycerides &gt; 2,3 mmol/L

          -  chronic diseases (such as diabetes, cardiovascular disease, kidney and liver
             dysfunction)

          -  use of cholesterol lowering medication

          -  use of blood pressure lowering medication

          -  high alcohol intake

          -  BMI &gt; 30

          -  pregnant and lactation women

          -  unusual dietary requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingeborg Brouwer, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martijn Katan, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University of Amsterdam</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wageningen University, Division of Human Nutrition</name>
      <address>
        <city>Wageningen</city>
        <zip>6703 HD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2007</study_first_submitted>
  <study_first_submitted_qc>September 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2007</study_first_posted>
  <last_update_submitted>January 10, 2008</last_update_submitted>
  <last_update_submitted_qc>January 10, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2008</last_update_posted>
  <keyword>CLA</keyword>
  <keyword>Industrial trans fatty acids</keyword>
  <keyword>Oleic acid</keyword>
  <keyword>Controlled dietary trial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

